---
category: news
title: "AI-formulated medicine to be tested on humans for the first time"
excerpt: "A drug designed entirely by artificial intelligence is about to enter clinical human trials for the first time. The drug, which is intended to treat obsessive-compulsive disorder, was discovered using AI systems from Oxford-based biotech company Exscientia. While it would usually take around four and a half years to get a drug to this stage of ..."
publishedDateTime: 2020-02-03T09:15:00Z
webUrl: "https://www.engadget.com/2020/02/03/ai-formulated-medicine-tested-humans-trial-first/"
ampWebUrl: "https://www.engadget.com/amp/2020/02/03/ai-formulated-medicine-tested-humans-trial-first/"
cdnAmpWebUrl: "https://www-engadget-com.cdn.ampproject.org/c/s/www.engadget.com/amp/2020/02/03/ai-formulated-medicine-tested-humans-trial-first/"
type: article
quality: 87
heat: 107
published: true

provider:
  name: Engadget
  domain: engadget.com
  images:
    - url: "/assets/images/organizations/engadget.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://o.aolcdn.com/images/dims?thumbnail=600%2C350&quality=80&image_uri=https%3A%2F%2Fo.aolcdn.com%2Fimages%2Fdims%3Fcrop%3D6294%252C3923%252C639%252C0%26quality%3D85%26format%3Djpg%26resize%3D1600%252C997%26image_uri%3Dhttps%253A%252F%252Fs.yimg.com%252Fos%252Fcreatr-images%252F2019-10%252F27840430-f413-11e9-bdfc-1e60bbd37912%26client%3Da1acac3e1b3290917d92%26signature%3D79d1e8cd28bb5cdf1601ea05d7226f489d22eb6c&client=amp-blogside-v2&signature=5c83968906b4c6d0967bda40cb3845b8a7ec6b23"
    width: 600
    height: 350
    title: "AI-formulated medicine to be tested on humans for the first time"

related:
  - title: "Medicine created by artificial intelligence to treat obesessive-compulsive disorder first time"
    excerpt: "It has been created by a British start-up called Exscientia and Japanese pharmaceutical firm called Sumitomo Dainippon Pharma. Artificial intelligence has invented a drug molecule that will be used to treat patients who have obsessive-compulsive disorder (OCD) for the first time. It has been created by a British start-up called Exscientia and ..."
    publishedDateTime: 2020-01-31T08:41:00Z
    webUrl: "https://www.wionews.com/world/latest-world-news-medicine-created-by-artificial-intelligence-to-treat-obesessive-compulsive-disorder-first-time-277753"
    ampWebUrl: "https://www.wionews.com/world/latest-world-news-medicine-created-by-artificial-intelligence-to-treat-obesessive-compulsive-disorder-first-time-277753/amp"
    cdnAmpWebUrl: "https://www-wionews-com.cdn.ampproject.org/c/s/www.wionews.com/world/latest-world-news-medicine-created-by-artificial-intelligence-to-treat-obesessive-compulsive-disorder-first-time-277753/amp"
    type: article
    provider:
      name: WION
      domain: wionews.com
    quality: 47
    images:
      - url: "https://cdn.wionews.com/sites/default/files/styles/story_page/public/2019/02/14/83987-untitled-design.jpg?itok=cVucXcjV"
        width: 918
        height: 506
  - title: "Artificial intelligence-created medicine to be used on humans for first time"
    excerpt: "A drug molecule \"invented\" by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine. It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma. The drug will be used to treat patients who have obsessive-compulsive disorder (OCD). Typically ..."
    publishedDateTime: 2020-01-30T17:40:00Z
    webUrl: "https://www.bbc.co.uk/news/technology-51315462"
    type: article
    provider:
      name: BBC
      domain: bbc.co.uk
    quality: 34
    images:
      - url: "https://ichef.bbci.co.uk/news/1024/branded_news/11559/production/_110710017_aidrug.gif"
        width: 1024
        height: 576

secured: "sm2PQihypERSturHMev8C9fjDFsuV227jprHyKJYTMphOm9I1PQhPz8umufSzzigr8koo/Y/TFu28msDiBX0cihy/qijW4PiXv9nJEFr6Cn7HXeiKzVv0CRpvLS186/fyQLap7fzD80P7JjO6qtefvd+/EdAPV3KBzjJzeD4NE+o5VN86Mr+hSjp4UlkcnlpfnLb2Ycnitmd+tOpLMgba22CLIeJg5/cv9ygAvbV/xxquSCyRkJax1F4nL3XSBL1ErBzO197AgvXR7lM8CLrUktMFdZEUFsoffaVrRnpcWam+c6bEV9YCHL7sqW/CNdhSInZJoYK9fOCQvA2kfAC6PQao+evSjDDEAGkyiQN0ri+Knn+FHWzUaII1iuwdrddl/udecb1+hlYST0UPmtyfkNXKREkIz7vfrj3ua1oquM9m2TOAwmFDpG6oVjaJ4EUAWWCJ8bXX0dksMqlmmYG/6Md7WJtDB7JLFVOU0OQLe8=;/NLjSG/1tSMHHfV8K88e/w=="
---

